CA
NZ
UK
AU
IND
US
Ecolab Inc. disclosed second quarter 2026 financial results on July 28, 2026, alongside announcements regarding a restructuring initiative. The company, a leading provider of water, hygiene and energy technologies and services, released detailed earnings data and supplemental information to support investor and analyst discussions. …
Hubbell Incorporated announced its financial results for the second quarter and six-month period ended June 30, 2026, on July 28, 2026. The Connecticut-based electrical and utility solutions manufacturer disclosed operational performance through a formal earnings announcement filed with the Securities and Exchange Commission. The …
Actuate Therapeutics, (NASDAQ:ACTU) a clinical-stage biopharmaceutical company built around the GSK-3β inhibitor elraglusib, reported statistically significant overall-survival data from a randomized Phase 2 pancreatic-cancer trial in January 2026 and is working to translate earlier pediatric-cancer signals in Ewing sarcoma and neuroblastoma into a registration-directed …
Aether Holdings, Inc. (NASDAQ:ATHR), a New York-based financial-media company that runs nine investor newsletters and is rolling out an AI agent suite called ALPHID, has spent its first 15 months as a public company burning cash faster than it collects revenue. A new Southeast …
Airship AI (NASDAQ:AISP) Holdings has landed a fresh seven-figure follow-on contract from an unnamed Fortune 100 transportation and e-commerce customer, adding to a first-quarter 2026 that showed accelerating revenue and improving gross margin. But a stockholders' deficit, thin backlog, and tens of millions of …
Akebia (NASDAQ:AKBA) Therapeutics and U.S. Renal Care stopped the VOICE trial early in June 2026 after an interim look showed Vafseo cut hospitalizations significantly versus a standard anemia drug, a result the companies called overwhelming. Layered on a still-loss-making Vafseo launch and fading Auryxia …
Aldeyra (NASDAQ:ALDX) Therapeutics is regrouping after a third Complete Response Letter for reproxalap in dry eye disease, delivered March 17, 2026. With a Type A meeting request in motion, roughly $65 million in cash, an unexercised AbbVie licensing option, and a broader immune-disease pipeline …
Altisource Portfolio Solutions S.A. (NASDAQ:ASPS), a Luxembourg société anonyme trading as ASPS on Nasdaq, posted its fourth straight quarter of double-digit service-revenue growth on July 23, 2026, even as profitability slipped. With a 2025 debt restructuring behind it, a shrinking Onity concentration and a …
Anavex Life Sciences Corp. (NASDAQ:AVXL) enters the second half of 2026 rebuilding its executive suite while absorbing a withdrawn European marketing application for blarcamesine, its lead Alzheimer's candidate. A departed CEO, an interim successor, a delinquent quarterly filing and a Nasdaq compliance notice have …
Antalpha Platform Holding Company (NASDAQ:ANTA), a Bitcoin-collateralized lender tied closely to Bitmain, is now promoting artificial intelligence and tokenized gold as new growth vectors. First-quarter 2026 revenue rose 52% year over year, but most of the balance sheet still runs through one related-party funding …
Please wait processing your request...